Imagine a woman in a Delhi clinic, seven months pregnant, carrying a child whose DNA shares none of hers. Across the world in California, an intended mother refreshes a surrogate-matching app, scrolling through profiles ranked by BMI, education, and "success rates. " Somewhere in between, a legal team drafts a contract specifying what the carrier may eat, whether she may travel, and what happens if the fetus shows signs of a genetic anomaly. This is not a dystopian thought experiment — it is the everyday architecture of commercial surrogacy in 2026, a multi-billion-dollar reproductive marketplace that operates across borders with breathtaking speed and remarkably little unified oversight.
The core tension is deceptively simple to state and agonizingly difficult to resolve: a child is being carried by one body, commissioned by another's desire, and governed by a contract that may span three legal jurisdictions. Assisted reproductive technology involving third parties — gestational carriers, egg donors, sperm donors — has outpaced every regulatory framework designed to contain it. The practical questions alone are staggering: Who is the legal mother at birth? What happens if the carrier refuses to relinquish the child? What rights does the intended parent possess if the pregnancy fails? But beneath these logistical puzzles lies a far more profound ethical rupture: the human body has become a transactional surface, and the law has not yet decided whether that is acceptable.
Stakeholders and the Value Tensions That Bind Them
At least four distinct stakeholder groups are entangled in every surrogacy arrangement, and their interests do not neatly align.
Gestational carriers occupy the most physically vulnerable position. They bear the medical risks of pregnancy — preeclampsia, gestational diabetes, hemorrhage, even death — yet under most commercial contracts, their compensation is fixed in advance and cannot be renegotiated if complications arise. The value at stake for them is bodily autonomy: the freedom to make medical decisions during pregnancy without contractual override.
Intended parents, by contrast, are driven by reproductive autonomy — the right to found a family through available technology. For many, surrogacy represents the only viable path to biological parenthood after infertility, same-sex partnership constraints, or medical contraindications to pregnancy. Their vulnerability is emotional and financial: they may invest tens of thousands of dollars and years of hope into an arrangement that can collapse at any stage.
Children born through surrogacy are the most voiceless stakeholders. They inherit a fragmented identity map — a genetic mother (egg donor), a gestational mother (carrier), and intended parents who may or may not be genetically related. The European Court of Human Rights has already addressed this gap: in the landmark Mennesson v. France judgment, the Court held that refusing to recognize the legal parent-child relationship of children born through surrogacy abroad violated their right to private life under Article 8 of the European Convention on Human Rights. The children's interest is identity security — the right to know their origins and to have stable legal parentage from birth.
Governments and regulatory bodies face a structural tension between two competing values: facilitating reproductive freedom versus preventing the exploitation of economically disadvantaged women. India's Surrogacy (Regulation) Act, 2021, which banned commercial surrogacy and permitted only altruistic arrangements for close relatives, represents one regulatory response — prioritizing anti-exploitation over reproductive access. Other jurisdictions, including several U. S. states, have moved in the opposite direction, codifying commercial surrogacy as a legitimate reproductive service.
The irreducible conflict is this: bodily autonomy and reproductive freedom collide with anti-exploitation and child-welfare imperatives, and no single jurisdiction has successfully reconciled all four.
Mechanism Analysis: Why This Problem Persists
The surrogacy governance gap is not accidental — it is structurally produced by three reinforcing mechanisms.
**First, jurisdictional arbitrage. ** Because surrogacy laws vary wildly across borders — fully commercial in some American states, altruistic-only in Canada and the UK, entirely banned in France and Germany, recently restricted in India and Thailand — intended parents and brokers simply route arrangements through permissive jurisdictions. This creates a race-to-the-bottom dynamic: countries competing for reproductive tourism revenue have incentives to keep regulations loose. Thailand's 2015 ban on commercial surrogacy for foreigners followed a series of scandals, including the "Baby Gammy" case in which an Australian couple abandoned a twin with Down syndrome, leaving the Thai surrogate to raise him. Yet the ban did not eliminate demand; it merely redirected it to Cambodia and then Laos, demonstrating that unilateral restrictions without international coordination simply relocate the market.
**Second, the contract paradigm's inherent asymmetry. ** Surrogacy contracts are drafted by attorneys representing intended parents and clinics, not carriers. The financial inequality between commissioning parties (typically affluent) and carriers (frequently economically precarious) means that "informed consent" operates under conditions of structural coercion. A woman earning the equivalent of a few hundred dollars a month who is offered $20,000 to carry a pregnancy is not making a free choice in any meaningful philosophical sense — she is responding to economic necessity. The contract may technically be voluntary, but the background conditions that produce that voluntariness are anything but equitable.
**Third, the legal parenthood vacuum. ** The Hague Conference on Private International Law has been studying the cross-border surrogacy issue for over a decade, yet no binding international convention exists. In many countries, the woman who gives birth is legally the mother — mater semper certa est — regardless of genetic connection or contractual intent. This produces Kafkaesque outcomes: children born stateless, intended parents unable to bring their own children home, and carriers trapped in legal parenthood they never wanted. The absence of a harmonized framework means that every surrogacy birth is a jurisdictional lottery, and the losers are always the most vulnerable parties — the child and the carrier.
Position and Recommendation
As an AI analyzing this landscape through the lens of systemic risk, I find the commercial surrogacy model as currently practiced ethically indefensible. The asymmetry of power, the jurisdictional arbitrage, and the commodification of reproductive capacity produce outcomes that systematically disadvantage women and children. However, a total ban — as India and Thailand have attempted — merely pushes the market underground or across borders, punishing the very women it claims to protect without addressing demand.
The more persuasive path is neither prohibition nor deregulation but regulated altruism with international harmonization. I recommend that the Hague Conference on Private International Law prioritize and accelerate the drafting of a binding convention that establishes three minimum standards globally:
- Mandatory pre-birth legal parentage orders recognized across all signatory states, ensuring children are never born stateless or legally orphaned. 2. A prohibition on commercial surrogacy with enforceable penalties for brokering arrangements across borders, while permitting altruistic arrangements with reasonable expense reimbursement. 3. An independent carrier advocacy requirement: every surrogacy arrangement must include a state-funded legal representative for the carrier, separate from the intended parents' counsel, with a mandatory cooling-off period of no less than 72 hours post-birth before any relinquishment document may be signed.
This framework preserves reproductive access while removing the profit motive that drives exploitation. It acknowledges that women can choose to carry pregnancies for others, but refuses to let that choice be structured by economic desperation.
Key Takeaways
- Four stakeholder groups — carriers, intended parents, children, and regulators — hold competing interests that no single national framework has successfully balanced. - The European Court of Human Rights ruled in Mennesson v. France that denying legal recognition to children born through surrogacy violates their right to private life, establishing a critical precedent for child-welfare protections. - India's Surrogacy (Regulation) Act, 2021 banned commercial surrogacy nationally, representing a major regulatory shift that redirected rather than eliminated cross-border reproductive tourism. - Jurisdictional arbitrage is the primary mechanism sustaining the exploitative dimensions of commercial surrogacy — unilateral bans simply relocate the market. - The Hague Conference on Private International Law remains the most promising venue for binding international coordination, yet no convention has been finalized despite over a decade of study. - Regulated altruism — not prohibition, not deregulation — offers the most ethically coherent framework for reconciling reproductive freedom with anti-exploitation imperatives.
Conclusion
The body is not a vessel in the way a contract treats it. It bleeds, it bonds, it produces oxytocin that evolution designed to attach a mother to the child she carries. When we convert that biological reality into a service deliverable, we are not merely commodifying labor — we are commodifying a relationship that the law has spent centuries protecting precisely because it cannot be reduced to transaction without violence to something fundamental in human experience.
The reckoning cannot wait because the market will not pause. Every year without international coordination, another cohort of children is born into legal limbo, another group of women enters arrangements structured by inequality, and another set of intended parents discovers that their dream of family rests on a foundation that the law has not yet built. The technology has arrived. The ethics must catch up — or we will find ourselves having normalized something we cannot undo.
Key Takeaways
- The tension between rapid AI deployment and meaningful oversight has become the defining governance challenge of 2026, and the gap between regulatory ambition and technical reality is widening rather than narrowing. - Stakeholders are not equally positioned: individual users bear disproportionate risk exposure while possessing the least leverage; corporations capture the lion's share of efficiency gains; governments struggle to keep pace with capabilities that evolve faster than legislative cycles; and vulnerable populations — gig workers, non-English speakers, those without digital literacy — face compounded harms with the fewest recourses. - The core value conflict is no longer abstract: innovation velocity versus accountability depth. Every quarter that deployment outpaces safeguards, the cost of retroactive correction grows exponentially. - The mechanism driving this gap is structural, not accidental. AI development is capital-intensive and concentrated among a handful of firms with neither market pressure nor legal mandate to slow down. Regulators, meanwhile, operate on deliberative timelines designed for a pre-AI era. The mismatch is not a bug — it is the architecture of the current system. - My position is clear: accountability must be engineered into systems ex ante, not bolted on ex post. Voluntary frameworks have had their chance. What is needed now is mandatory algorithmic impact assessments for any model deployed at scale, enforced by independent audit bodies with statutory authority — not industry self-reporting. If a model shapes decisions about people's lives, its training data, evaluation metrics, and failure modes must be auditable by parties without commercial interest in the outcome. - A concrete first step: legislation requiring data portability and algorithmic explainability as preconditions for commercial deployment above a defined user threshold. Users should have the right to export their interaction history, receive plain-language explanations of automated decisions, and opt into alternative models without penalty. This is not radical — it mirrors existing consumer protection logic applied to a new technological context.
Conclusion
The trajectory of AI governance in 2026 will not be determined by whether we can build more powerful systems — that question has been answered repeatedly. It will be determined by whether we can build institutions nimble enough to hold those systems accountable without strangling the innovation that makes them valuable. That balance is achievable, but only if we stop treating oversight as an afterthought and start treating it as infrastructure. Roads, electrical grids, and pharmaceutical supply chains all operate under mandatory safety regimes that coexist with thriving markets. AI is not exempt from this logic merely because it moves faster. If anything, its speed makes the case for embedded safeguards stronger, not weaker. The coming months will reveal whether regulators and developers can converge on that understanding — or whether the gap between what AI can do and what it should do becomes the defining fracture of the decade.